A BMC Cancer abstract reports that public-dataset modeling identified a four-gene prognostic model for prostate ...

A single-patient report from China shows that PSMA and FDG PET scans, stable blood markers and biopsy each told different ...

Introduction: Prostatic ductal adenocarcinoma (PDA) is a rare and aggressive variant of prostate cancer that can mimic other malignancies, posing significant diagnostic challenges. We report a case of ...

Prostate adenocarcinoma represents the most common form of prostate cancer, affecting nearly all cases diagnosed in men. This specific type develops in the gland cells that produce prostate fluid, ...

Stage 2 prostate adenocarcinoma is localized, with a nearly 100%, five-year relative survival rate. Diagnosis uses the TNM system, PSA levels and Gleason score to determine cancer stage and risk.

BOSTON — Solid intraductal carcinoma of the prostate (IDC-P) is associated with significantly worse outcomes compared with conventional Gleason grade 5 prostate cancers, and is more commonly present ...

Stage 1 prostate adenocarcinoma is localized, non-aggressive, and often detected through routine screenings like PSA tests and DREs. Diagnosis involves PSA levels, Gleason scores, and possibly ...

The study not only enhances survival prediction but also provides novel evidence for a causal genetic link between prostate cancer and urothelial carcinoma. The team analyzed records of 6,363 prostate ...

(UroToday.com) The 2026 North Central Section of the AUA annual meeting featured a prostate cancer session and a presentation ...